Monoclonal antibody successes in the clinic
- PMID: 16151394
- DOI: 10.1038/nbt0905-1073
Monoclonal antibody successes in the clinic
Abstract
Most monoclonal antibodies in clinical trials are owned by small biotech companies. But with blockbuster-sized revenues and approval rates higher than those for small-molecule drugs, that all may be set to change.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources